CD19 and Miyoshi myopathy: In our study, we found that the percentage of the CD19+CD24hiCD38hi Bregs in BMMCs was significantly higher in patients with MM as compared with the percentage of the CD19+CD24hiCD38hi Bregs in PBMCs in HVs, which was in agreement with the immunosuppressive properties of Bregs reported by Zhang et al. [29].